Hogan Lovells Events | 7 October 2024 | 2:00 p.m. - 3:45 p.m. (ET)

CLE

Part I: AI and Legal Ethics

To comply with their ethical obligations -- including the duties of competence, communication, candor, confidentiality and supervision -- lawyers must understand the risks and benefits of Generative Artificial Intelligence before using it to provide legal services. Using several hypothetical scenarios as a starting point, we will analyze these issues under the California Rules of Professional Conduct, the New York Rules of Professional Conduct, and the Pennsylvania Rules of Professional Conduct. We will also examine recent guidance on lawyers’ use of AI provided by several state bars and court systems.

Part II: Powering Clinical Trials, Commercialization, & Sustainable Access to Innovative Medicines

The session will cover: (i) State of AI in life sciences: US legislation, emerging trends, key priorities; (ii) Enterprise AI – How the pharma industry is leveraging AI to propel holistic results (R&D, clinical development, operations, among others); (iii) Future proofing – AI governance in the context of commercialization and beyond; (iv) From Hype to Reality – case studies and examples to drive innovation; and (v) Strategic Considerations for AI Integration and Compliance.

Register here


Back To Listing

From Hogan Lovells

Rebecca C. Mandel

Rebecca C. Mandel

Partner
Washington, D.C.

Melissa K. Bianchi

Melissa K. Bianchi

Partner
Washington, D.C.

Lowell M. Zeta

Lowell M. Zeta

Partner
Washington, D.C.